Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
BioCryst Pharmaceuticals Inc banner

BioCryst Pharmaceuticals Inc
SWB:BO1

Watchlist Manager
BioCryst Pharmaceuticals Inc Logo
BioCryst Pharmaceuticals Inc
SWB:BO1
Watchlist
Price: 7.78 EUR -0.1% Market Closed
Market Cap: €1.6B
Write Note Create Alert Ask AI

Intrinsic Value

Is BO1 undervalued or overvalued?

See the intrinsic value estimate for BioCryst Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

BO1 Intrinsic Value
LOCKED
Unlock
Today vs. history

BO1 looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with BO1’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor BO1
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Margin of Safety 20% Locked
Current Price €7.78
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to BO1

Fundamental Analysis

What BioCryst Pharmaceuticals Does

Biotechnology Health Care

BioCryst Pharmaceuticals is a biotechnology company that makes medicines for rare diseases, with a strong focus on hereditary angioedema, a genetic condition that causes repeated swelling attacks. Its main marketed product is Orladeyo, an oral preventive treatment that patients take long term. The company also develops other drug candidates for rare immune and inflammatory disorders, but its business is built around selling specialty medicines rather than broad consumer health products.

Headquarters
United States of America US
Employees
435
IPO date
Mar 4, 1994
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
BioCryst Pharmaceuticals Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

BCRX Insider Trading
Buy and sell transactions by insiders

Continue BO1 Research

Summary
BO1 intrinsic value, competitors valuation, and company profile.
DCF Valuation
BO1 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BO1 stock valuation using valuation multiples.
Wall St Estimates
BO1 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BO1 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other BioCryst Pharmaceuticals Inc listings:
NASDAQ • USD
BCRX
 F • EUR
BO1
 XMUN • EUR
BO1
Discover More
What is the Intrinsic Value of one BO1 stock?

The intrinsic value for BioCryst Pharmaceuticals Inc (BO1) under the Base Case is hidden EUR.

Is BO1 stock undervalued or overvalued?

Compared with the current market price of 7.78 EUR, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 362,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.